Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Brian W. James"'
Autor:
Aasha I. Hoogland, Reena V. Jayani, Aaron Collier, Nathaly Irizarry‐Arroyo, Yvelise Rodriguez, Michael D. Jain, Margaret Booth‐Jones, Kelly A. Hyland, Brian W. James, Anna Barata, Christina A. Bachmeier, Julio C. Chavez, Farhad Khimani, Gabriel S. Krivenko, Aleksandr Lazaryan, Hien D. Liu, Taiga Nishihori, Javier Pinilla‐Ibarz, Bijal D. Shah, Muneer Abidi, Frederick L. Locke, Heather S. L. Jim
Publikováno v:
Cancer Medicine, Vol 10, Iss 6, Pp 1936-1943 (2021)
Abstract Chimeric antigen receptor T‐cell therapy with axicabtagene ciloleucel (axi‐cel) has considerably improved survival in adults with relapsed/refractory large B‐cell lymphoma. This study reports patient‐reported outcomes (PROs) such as
Externí odkaz:
https://doaj.org/article/4e712b76e8e5405caf6b6c0634f8f50e
Autor:
Jim, Aasha I. Hoogland, Brent J. Small, Laura B. Oswald, Crystal Bryant, Yvelise Rodriguez, Brian D. Gonzalez, Xiaoyin Li, Michelle C. Janelsins, Hailey W. Bulls, Brian W. James, Bianca Arboleda, Claudia Colon-Echevarria, Mary K. Townsend, Shelley S. Tworoger, Paulo C. Rodriguez, Julienne E. Bower, Sachin M. Apte, Robert M. Wenham, Heather S. L.
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3407
Previous research suggests that inflammation triggers cancer-treatment-related symptoms (i.e., fatigue, depression, and disruptions in sleep and physical activity), but evidence is mixed. This study examined relationships between inflammatory biomark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::bfed7b5418b116285baf733304289caa
Autor:
Ashley M. Nelson, Brian W James, Noelle L. Williams, Brent J. Small, Hailey W. Bulls, Elizabeth A. Lafranchise, Kelly A. Hyland, Brian D. Gonzalez, Kelly Maharaj, Raviteja Alla, Brittany Kennedy, Laura B. Oswald, Jori Mansfield, Heather S.L. Jim, Sarah L. Eisel, Sarah L. Jennewein, Aasha I. Hoogland, Shannon M Christy, Adam P. Dicker, Susan J. Sharpe, Kristina E Bowles, Michael A. Postow
Publikováno v:
J Natl Cancer Inst
Background Trials of immune checkpoint inhibitors (ICIs) have published patient-reported quality of life (QOL), but the size and heterogeneity of this literature can make patient education difficult. This meta-analysis aimed to describe change in QOL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7949c9e3a818ade079d883fe9e1280a0
https://doi.org/10.1093/jnci/djab171
https://doi.org/10.1093/jnci/djab171
Autor:
Reena Jayani, Heather S.L. Jim, Yvelise Rodriguez, Gabriel S Krivenko, Bijal D. Shah, Muneer H. Abidi, Brian W James, Julio C. Chavez, Michael D. Jain, Anna Barata, Margaret Booth-Jones, Nathaly Irizarry-Arroyo, Javier Pinilla-Ibarz, Christina A Bachmeier, Kelly A. Hyland, Hien D. Liu, Farhad Khimani, Taiga Nishihori, Aasha I. Hoogland, Frederick L. Locke, Aleksandr Lazaryan, Aaron Collier
Publikováno v:
Cancer Medicine, Vol 10, Iss 6, Pp 1936-1943 (2021)
Cancer Medicine
Cancer Medicine
Chimeric antigen receptor T‐cell therapy with axicabtagene ciloleucel (axi‐cel) has considerably improved survival in adults with relapsed/refractory large B‐cell lymphoma. This study reports patient‐reported outcomes (PROs) such as quality o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e22f22df8b20571c19604d98195668d
https://doaj.org/article/4e712b76e8e5405caf6b6c0634f8f50e
https://doaj.org/article/4e712b76e8e5405caf6b6c0634f8f50e
Autor:
Brian W James, Hailey W. Bulls, Heather S.L. Jim, Bianca L. Arboleda, Brent J. Small, Mian M K Shahzad, Brittany Kennedy, Brian D. Gonzalez, Aasha I. Hoogland
Publikováno v:
Ann Behav Med
Background Chemotherapy-induced peripheral neuropathy (CIPN) is well-documented and can become chronic for up to a third of patients. CIPN management is hampered by limited pharmacological options. Thus, identifying modifiable behaviors that influenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2d833811b0f0322071a951d91b5b427
https://doi.org/10.1093/abm/kaaa101
https://doi.org/10.1093/abm/kaaa101
Autor:
Aasha I. Hoogland, Anna Barata, Jennifer Logue, Anuhya Kommalapati, Kelly A. Hyland, Ashley M. Nelson, Sarah L. Eisel, Brent J. Small, Brian W. James, Shannon M. Christy, Hailey W. Bulls, Margaret Booth-Jones, Reena V. Jayani, Michael D. Jain, Sepideh Mokhtari, Julio C. Chavez, Aleksandr Lazaryan, Bijal D. Shah, Frederick L. Locke, Heather S.L. Jim
Publikováno v:
Transplantation and Cellular Therapy. 28:305.e1-305.e9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d380d0eabd566f884f4fdb2c1b45d969
https://doi.org/10.1016/j.jtct.2022.03.023
https://doi.org/10.1016/j.jtct.2022.03.023
Autor:
Ashley M. Nelson, S.M. Christy, H.S.L. Jim, Michael A. Postow, Brent J. Small, Hailey W. Bulls, Adam P. Dicker, Sarah L. Eisel, Kamira Maharaj, Brian D. Gonzalez, Susan J. Sharpe, K.E. Bowles, Elizabeth A. Lafranchise, Raviteja Alla, Brian W James, Brittany Kennedy, Jori Mansfield, Aasha I. Hoogland, Noelle L. Williams, Kelly A. Hyland
Publikováno v:
Annals of Oncology. 31:S956
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12118b971a307d9c7346e153eb8b1fc7
https://doi.org/10.1016/j.annonc.2020.08.2051
https://doi.org/10.1016/j.annonc.2020.08.2051
Autor:
Aasha I. Hoogland, Christine H. Chung, Brian W James, Nathaly Irizarry-Arroyo, Jameel Muzaffar, Kedar Kirtane, Heather S.L. Jim, Julie A. Kish
Publikováno v:
Cancer Research. 80:5751-5751
Background: Immune checkpoint inhibitors (ICIs) (i.e. nivolumab, pembrolizumab) are FDA-approved agents used in the treatment of various head and neck malignancies. While much is known about clinician-rated adverse clinical events of these immunother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28eb71173e431109dd9bc295ada9809e
https://doi.org/10.1158/1538-7445.am2020-5751
https://doi.org/10.1158/1538-7445.am2020-5751
Autor:
Elizabeth A. Lafranchise, Nathaly Irizarry-Arroyo, Brian W James, Aasha I. Hoogland, Jori Mansfield, Sarah L. Eisel, Heather S.L. Jim
Publikováno v:
Innovation in Aging
Immune checkpoint inhibitors (ICIs) have generated significant excitement for their ability to extend survival in patients with lung, head and neck, and other cancers. In older adults with cancer, emerging research suggests that ICIs improve overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a5867e5e453bd322dc3de86446634e3
http://europepmc.org/articles/PMC6840132
http://europepmc.org/articles/PMC6840132